Protocol for lentiviral engineering and multi-omic characterization of human kidney tubuloids

  • Giulia Perticari
  • , Maroussia M.P. Ganpat
  • , Jarno Drost*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Organoids derived from normal human tissue have proven to be effective preclinical models for studying tumor progression through the introduction of driver mutations. In this protocol, we outline techniques for disease modeling using organoids derived from healthy kidney tissue, also known as tubuloids. We provide step-by-step instructions for the establishment and passaging of tubuloids, lentiviral transduction, processing for histological analysis, and preparation for CUT&RUN and single-cell transcriptomic profiling. For complete details on the use and execution of this protocol, please refer to Ganpat et al.

Original languageEnglish
Article number104362
Number of pages21
JournalSTAR Protocols
Volume7
Issue number1
DOIs
Publication statusPublished - 20 Mar 2026

Bibliographical note

Publisher Copyright:
© 2026 The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Protocol for lentiviral engineering and multi-omic characterization of human kidney tubuloids'. Together they form a unique fingerprint.

Cite this